Pharma
Novo Nordisk announces rebrand amid competition with Eli Lilly
The two pharma giants are in competition for dominance in the obesity and diabetes markets.
Pharma
Latest news and analysis on pharma from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Pharma
Oncologists say newly approved pancreatic cancer drug is a breakthrough for treatment
The medicine doubled survival time for patients in a Phase 3 clinical trial.
Pharma
Moderna and Merck’s positive preliminary cancer vaccine results could signal a ‘new era’ of cancer treatment, expert says
The companies say the treatment slowed melanoma recurrence and spread in the trial.
Pharma
Novo and Lilly race to bring next-generation GLP-1s to market
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
Pharma
Amazon, Novo Nordisk partner on AI-driven drug discovery
It’s one of a growing number of partnerships between the pharmaceutical and, tech industries.
Pharma
What to know about pharmaceutical tariffs
Experts say tariffs are creating uncertainty and shaking up biotech playbooks.
Pharma
Pharma companies home in on GLP-2s and GLP-3s in race to innovate on obesity treatments
Companies are looking at combining several hormone-like molecules to boost results.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
